Pomalidomide plus bortezomib and dexamethasone for newly diagnosed multiple myeloma with renal impairment: Randomized phase II study (POM-MM-003). (linkinghub.elsevier.com)

Authors: Xiao F … Hou J Journal: Cell Med Published: 2026-09-09 DOI: https://doi.org/10.1016/j.medj.2026.101293